Resistance to CSF-1R inhibitors is likely mediated through the interaction of insulin-like growth factor-1 (IGF-1) and tumor cell IGF-1 receptor (IGF-1R), causing an upregulation of the phosphoinositide 3-kinase (PI3K) pathway [32]. Here, IGF1 is linked to neoplasm.